Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login
Market Place

List of Drug Master Files (DMF) of Dyazide Active Pharmaceutical Ingredient (API) submitted to the U.S. FDA. Original Data : FDA Website

Client Email

Product

Dyazide
Triamterene
USDMF

PharmaCompass Sponsored Ads

Contact Supplier

Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

Contact Supplier

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

xyz-pharma-m-2024-09-09

Contact Supplier

Dyazide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

61 API Suppliers, 31 USDMF, 22 CEP/COS, 8 JDMF, 10 EU WC, 17 KDMF, 18 NDC API, 28 Listed Suppliers, $ API Reference Price

61 API Suppliers
31 USDMF
22 CEP/COS
8 JDMF
10 EU WC
17 KDMF
18 NDC API
28 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

PRICE INFORMATION

API Reference Price, API Exports, API Imports, FDF Exports, FDF Imports

API Reference Price
API Exports
API Imports
FDF Exports
FDF Imports

INTERMEDIATES

3 API Suppliers

3 API Suppliers

FINISHED DOSAGE FORMULATIONS

3599 FDF Dossiers, 877 FDA Orange Book, 1902 Europe, 229 Canada, 2 Australia, 202 South Africa, 387 Listed Dossiers

3599 FDF Dossiers
877 FDA Orange Book
1902 Europe
229 Canada
2 Australia
202 South Africa
387 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 25MG;25MG, TABLET;ORAL - 50MG;50MG, CAPSULE;ORAL - 25MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG;37.5MG, TABLET;ORAL - 50MG;75MG, TABLET;ORAL - 10MG;25MG, TABLET;ORAL - 5MG;12.5MG, TABLET;ORAL - 12.5MG;10MG, TABLET;ORAL - 12.5MG;20MG, TABLET;ORAL - 25MG;20MG, TABLET;ORAL - 12.5MG;100MG, TABLET;ORAL - 12.5MG;50MG, TABLET;ORAL - 25MG;100MG, CAPSULE;ORAL - 12.5MG, TABLET;ORAL - 12.5MG;150MG, TABLET;ORAL - 12.5MG;300MG, TABLET;ORAL - 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 12.5MG;160MG, TABLET;ORAL - 12.5MG;320MG, TABLET;ORAL - 12.5MG;80MG, TABLET;ORAL - 25MG;160MG, TABLET;ORAL - 25MG;320MG, TABLET;ORAL - 16MG;12.5MG, TABLET;ORAL - 32MG;12.5MG, TABLET;ORAL - 32MG;25MG, TABLET;ORAL - 12.5MG;40MG, TABLET;ORAL - 12.5MG;80MG, TABLET;ORAL - 25MG;80MG, TABLET;ORAL - 12.5MG;20MG, TABLET;ORAL - 12.5MG;40MG, TABLET;ORAL - 25MG;40MG, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;160MG, TABLET;ORAL - EQ 10MG BASE;25MG;320MG, TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG, TABLET;ORAL - EQ 5MG BASE;25MG;160MG, TABLET;ORAL - 25MG, TABLET;ORAL - 50MG

TABLET;ORAL - 25MG;25MG
TABLET;ORAL - 50MG;50MG
CAPSULE;ORAL - 25MG;37.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 25MG;37.5MG
TABLET;ORAL - 50MG;75MG
TABLET;ORAL - 10MG;25MG
TABLET;ORAL - 5MG;12.5MG
TABLET;ORAL - 12.5MG;10MG
TABLET;ORAL - 12.5MG;20MG
TABLET;ORAL - 25MG;20MG
TABLET;ORAL - 12.5MG;100MG
TABLET;ORAL - 12.5MG;50MG
TABLET;ORAL - 25MG;100MG
CAPSULE;ORAL - 12.5MG
TABLET;ORAL - 12.5MG;150MG
TABLET;ORAL - 12.5MG;300MG
TABLET;ORAL - 12.5MG;75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 25MG;300MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - 12.5MG;160MG
TABLET;ORAL - 12.5MG;320MG
TABLET;ORAL - 12.5MG;80MG
TABLET;ORAL - 25MG;160MG
TABLET;ORAL - 25MG;320MG
TABLET;ORAL - 16MG;12.5MG
TABLET;ORAL - 32MG;12.5MG
TABLET;ORAL - 32MG;25MG
TABLET;ORAL - 12.5MG;40MG
TABLET;ORAL - 12.5MG;80MG
TABLET;ORAL - 25MG;80MG
TABLET;ORAL - 12.5MG;20MG
TABLET;ORAL - 12.5MG;40MG
TABLET;ORAL - 25MG;40MG
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 100MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 25MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - 12.5MG;EQ 50MG TARTRATE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 150MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;12.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 300MG BASE;25MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET;ORAL - EQ 10MG BASE;12.5MG;160MG
TABLET;ORAL - EQ 10MG BASE;25MG;160MG
TABLET;ORAL - EQ 10MG BASE;25MG;320MG
TABLET;ORAL - EQ 5MG BASE;12.5MG;160MG
TABLET;ORAL - EQ 5MG BASE;25MG;160MG
TABLET;ORAL - 25MG
TABLET;ORAL - 50MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 1 Evonik, 3 Rochem International Inc, 25 SPI Pharma, 2 Seqens, 17 DKSH, 3 Jai Radhe Sales, 1 Pharm-RX Chemical, 10 Boai NKY Pharmaceuticals Ltd, 1 Chynops Pharma, 15 Gangwal Healthcare, 14 Nanjing Well Pharmaceutical, 2 Pfanstiehl, 4 ACG Worldwide, 10 Actylis, 1 Aeon Procare, 4 Alcedo Pharmachem, 12 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 39 BASF, 3 Clariant, 13 Corel Pharma Chem, 7 DFE Pharma, 1 Doshion Polyscience, 3 Finar, 13 Gangwal Chemicals, 1 Huzhou Sunflower Pharmaceutical, 7 Ideal Cures Pvt Ltd, 5 Ingredion Pharma Solutions, 39 Kerry, 4 Kima Chemical, 6 Lonza Capsugel, 20 Microlex e.U, 2 Nanjing Bold Chemical, 1 NEWEDGE Overseas, 2 Nomisma Healthcare, 5 Novo Excipients, 5 Pharmatrans-Sanaq, 8 Pluviaendo, 6 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 2 Qualicaps, 29 Roquette, 16 Seppic, 9 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 2 Shijiazhuang Huaxu Pharmaceutical, 12 Sigachi Industries, 3 The Dow Chemical Company, 3 Ulanqab Kema New Material, 2 Valens Pharmachem, 6 Vasa Pharmachem, 1 Vertellus, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

121 Fillers, Diluents & Binders, 62 Coating Systems & Additives, 60 Direct Compression, 51 Disintegrants & Superdisintegrants, 41 Solubilizers, 40 Thickeners and Stabilizers, 40 Granulation, 38 Controlled & Modified Release, 38 Lubricants & Glidants, 36 Film Formers & Plasticizers, 33 Topical, 31 Parenteral, 28 Taste Masking, 23 Co-Processed Excipients, 21 Chewable & Orodispersible Aids, 14 Emulsifying Agents, 10 API Stability Enhancers, 9 Empty Capsules, 8 Surfactant & Foaming Agents, 7 Rheology Modifiers, 5 Coloring Agents, 4 Vegetarian Capsules, 1 Soft Gelatin

121 Fillers, Diluents & Binders
62 Coating Systems & Additives
60 Direct Compression
51 Disintegrants & Superdisintegrants
41 Solubilizers
40 Thickeners and Stabilizers
40 Granulation
38 Controlled & Modified Release
38 Lubricants & Glidants
36 Film Formers & Plasticizers
33 Topical
31 Parenteral
28 Taste Masking
23 Co-Processed Excipients
21 Chewable & Orodispersible Aids
14 Emulsifying Agents
10 API Stability Enhancers
9 Empty Capsules
8 Surfactant & Foaming Agents
7 Rheology Modifiers
5 Coloring Agents
4 Vegetarian Capsules
1 Soft Gelatin

DIGITAL CONTENT

3 DATA COMPILATION #PharmaFlow, 145 NEWS #PharmaBuzz

3 DATA COMPILATION #PharmaFlow
145 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

8 US Medicaid Prescriptions, 1836 Finished Drug Prices, 16 Annual Reports

8 US Medicaid Prescriptions
1836 Finished Drug Prices
16 Annual Reports

MARKET PLACE

30 APIs, 18 FDF Dossiers

30 APIs
18 FDF Dossiers

PATENTS & EXCLUSIVITIES

4 US Patents

4 US Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 USP, 3 JP, 3 Others

3 EDQM
1 USP
3 JP
3 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 35 Xls

Filters

Reset all filters

Filters

FILTER :

filter Holder Reset all filters

31 All

01 1Polpharma

02 1Sanofi

03 2Abbott Laboratories

04 1Alembic Pharmaceuticals Limited

05 1Amoli Organics

06 1AstraZeneca

07 1Aurobindo Pharma Limited

08 1CTX Lifesciences

09 1Cambrex Corporation

10 2Changzhou Pharmaceutical Factory

11 1Daiichi Sankyo

12 2GSK

13 1Industriale Chimica

14 2Ipca Laboratories

15 1Macleods Pharmaceuticals Limited

16 1Medimpex

17 1Posh Chemicals P. Ltd

18 1Suzhou Lixin Pharmaceutical

19 2Teva API

20 3Unichem Laboratories Limited

21 1Zhejiang Huahai Pharmaceutical

22 1Zydus Lifesciences

23 2Blank

filter Subject Reset all filters

31 All

01 1CHLOROTHIAZIDE (BULK) - HYDROCHLOROTHIAZIDE

02 1CS-866-HYDROCHLOROTHIAZIDE TABLETS (CS-866HCTZ)

03 1DIHYDROCHLOROTHIAZIDE

04 12HYDROCHLOROTHIAZIDE

05 1HYDROCHLOROTHIAZIDE B.P.

06 1HYDROCHLOROTHIAZIDE IN PHIL PA

07 11HYDROCHLOROTHIAZIDE USP

08 1HYDROCHLOROTHIAZIDE USP - PROCESS #2

09 1HYDROCHLOROTHIAZIDE USP, PROCESS II

10 1METOPROLOL SUCCINATE EXTENDED RELEASE/HYDROCHLOROTHIAZIDE 25/12.5,50/12.5 AND100/12.5 TABLETS

filter Country Reset all filters

31 All

01 4China

02 1France

03 12India

04 2Israel

05 1Italy

06 1Japan

07 1Poland

08 3U.S.A

09 4United Kingdom

10 2Blank

filter Status Reset all filters

31 All

01 17Active

02 14Inactive

filter GDUFA DMF Review Reset all filters

31 All

01 15Complete

02 16Blank

Polpharma Hydrochlorothiazide

API Suppliers
USDMF
CEP/COS
JDMF
EU WC
KDMF
NDC API
Listed Suppliers

List of Suppliers

Product Main Page

01

Zaklady Farmaceutyczne Polpharma Sa

CPhI Worldwide, Milan

Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

Contact Supplier

Contact Supplier

Digital Content

Hydrochlorothiazide

GDUFA

DMF Review : Complete

Rev. Date : 2015-01-06

Pay. Date : 2014-12-29

DMF Number : 17599

Submission : 2004-08-12

Status : Active

Type : II

Product Web Link

Digital Content

02

Chinoin Pharmaceutcial And Chemical ...

CPhI Worldwide, Milan

Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Contact Supplier

Contact Supplier

Digital Content

Hydrochlorothiazide

GDUFA

DMF Review : N/A

Rev. Date :

Pay. Date :

DMF Number : 5125

Submission : 1983-11-07

Status : Inactive

Type : II

Sanofi Company Banner

Portfolio PDF

Product Web Link

Digital Content

03

Apitoria Pharma Private Ltd

USDMF

Formnext Forum

Not Confirmed

03

Apitoria Pharma Private Ltd

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Hydrochlorothiazide Usp

GDUFA

DMF Review : Complete

Rev. Date : 2013-01-08

Pay. Date : 2012-12-17

DMF Number : 17728

Submission : 2004-09-24

Status : Active

Type : II

Portfolio PDF

Product Web Link

Digital Content

04

Cambrex Profarmaco Milano Srl

USDMF

Formnext Forum

Not Confirmed

04

Cambrex Profarmaco Milano Srl

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Hydrochlorothiazide

GDUFA

DMF Review : Complete

Rev. Date : 2013-01-11

Pay. Date : 2012-12-11

DMF Number : 881

Submission : 1965-01-02

Status : Active

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

Changzhou Pharmaceutical Factory

USDMF

Formnext Forum

Not Confirmed

05

Changzhou Pharmaceutical Factory

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Hydrochlorothiazide

GDUFA

DMF Review : Complete

Rev. Date : 2013-10-05

Pay. Date : 2013-09-27

DMF Number : 16750

Submission : 2003-08-08

Status : Active

Type : II

Product Web Link

Digital Content

06

Ipca Laboratories Ltd

USDMF

Formnext Forum

Not Confirmed

06

Ipca Laboratories Ltd

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Hydrochlorothiazide Usp, Process Ii

GDUFA

DMF Review : Complete

Rev. Date : 2013-07-31

Pay. Date : 2013-07-17

DMF Number : 18563

Submission : 2005-11-11

Status : Active

Type : II

Product Web Link

Digital Content

07

Ipca Laboratories Ltd

USDMF

Formnext Forum

Not Confirmed

07

Ipca Laboratories Ltd

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Hydrochlorothiazide Usp

GDUFA

DMF Review : Complete

Rev. Date : 2012-11-11

Pay. Date : 2012-12-05

DMF Number : 16707

Submission : 2003-07-07

Status : Active

Type : II

Product Web Link

Digital Content

08

Teva Pharmaceutical Industries Ltd

USDMF

Formnext Forum

Not Confirmed

08

Teva Pharmaceutical Industries Ltd

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Hydrochlorothiazide

GDUFA

DMF Review : Complete

Rev. Date : 2012-11-30

Pay. Date : 2012-11-08

DMF Number : 4028

Submission : 1980-12-10

Status : Active

Type : II

Product Web Link

Digital Content

Corporate PDF

09

Teva Pharmaceutical Industries Ltd

USDMF

Formnext Forum

Not Confirmed

09

Teva Pharmaceutical Industries Ltd

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Hydrochlorothiazide

GDUFA

DMF Review : Complete

Rev. Date : 2012-11-30

Pay. Date : 2012-11-08

DMF Number : 2115

Submission : 1973-06-14

Status : Active

Type : II

Product Web Link

Digital Content

Corporate PDF

10

Unichem Laboratories Ltd

USDMF

Formnext Forum

Not Confirmed

10

Unichem Laboratories Ltd

Formnext Forum

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Hydrochlorothiazide Usp

GDUFA

DMF Review : Complete

Rev. Date : 2013-04-30

Pay. Date : 2013-04-23

DMF Number : 16278

Submission : 2002-11-26

Status : Active

Type : II

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2
3
Last

Dyazide Manufacturers | Traders | Suppliers

Dyazide Manufacturers, Traders, Suppliers 1

46

We have 22 companies offering Dyazide

Get in contact with the supplier of your choice:

Polpharma
Sanofi
Abbott Laboratories
Alembic Pharmaceuticals Limited
Amoli Organics
AstraZeneca
Aurobindo Pharma Limited
Cambrex Corporation
Changzhou Pharmaceutical Factory
CTX Lifesciences
Daiichi Sankyo
GSK
Industriale Chimica
Ipca Laboratories
Macleods Pharmaceuticals Limited
Medimpex
Posh Chemicals P. Ltd
Suzhou Lixin Pharmaceutical
Teva API
Unichem Laboratories Limited
Zhejiang Huahai Pharmaceutical
Zydus Lifesciences

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?